The enteral nutrition market is estimated to be valued at US$ 3.1 Bn in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Enteral nutrition products include formulas that provide nutrition through the gastrointestinal tract via a feeding tube, catheter, or stoma. The formulas are used for adults and pediatrics who cannot maintain weight and nutrition orally due to medical conditions or treatments. The enteral nutrition market caters to chronic disease indications such as cancer, gastrointestinal diseases, and neurological disorders.

Market Dynamics:
The growth of the enteral nutrition market is attributed to the increasing prevalence of chronic diseases globally. As per the National Cancer Institute data, the estimated number of cancer cases in 2023 is 1.8 million and the disease continues to be one of the leading causes of death in the U.S. Also, chronic gastrointestinal disorders such as Crohn's disease and ulcerative colitis are on the rise, contributing to the demand for specialized enteral formulas. Further, tube feeding formulas find widespread adoption in neurological conditions that impair oral feeding abilities such as Parkinson's disease and amyotrophic lateral sclerosis (ALS).

SWOT Analysis

Strengths:
- Growing aging population susceptible to chronic diseases increases demand
- Increasing adoption of tube feeding as it provides balanced nutrition
- Advanced technologies enabling customized and precise formulations

Weaknesses:
- High costs associated with enteral nutrition products hampers mass adoption
- Risks of complications from tube feeding can negatively impact the market

Opportunities:
- Expanding into developing countries provides lucrative opportunities for growth
- Innovations in product types catering to specific nutritional needs and conditions

Threats:
- Alternative oral nutrition supplements pose competition to enteral products
- Stringent regulations can delay new product launches

Key Takeaways

The global enteral nutrition market is expected to witness high growth, exhibiting CAGR of 5.8% over the forecast period, due to increasing prevalence of chronic diseases. The market size for 2023 is US$ 3.1 Bn.

The global enteral nutrition market is dominated by North America. This is attributed to the growing aging population, rising incidence of chronic diseases, and presence of major market players in the region. Europe is expected to grow at a steady pace during the forecast period due to rising research activities.

Key players operating in the enteral nutrition market are Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., Curtis Health Caps SP. The major players are focusing on new product launches and strategic collaborations to expand their market share.